← FDA DRUG APPROVALS

FDA ANDA · ANDA087881

LIDOCAINE HYDROCHLORIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA087881
TYPE
ANDA
ORIGINAL APPROVAL
1982-11-18
LATEST ACTION
2015-10-19
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

LIDOCAINE HYDROCHLORIDEPrescription
LIDOCAINE HYDROCHLORIDE 4% · SOLUTION · TOPICAL

Approval history

2015-10-19Labeling · Supplement 12 · standardAP
2002-08-13Manufacturing (CMC) · Supplement 11AP
2002-04-15Manufacturing (CMC) · Supplement 10 · unknownAP
1994-02-16Labeling · Supplement 9AP
1992-05-28Labeling · Supplement 8AP
1989-09-06Labeling · Supplement 7AP
1987-05-14Manufacturing (CMC) · Supplement 3AP
1983-10-06Manufacturing (CMC) · Supplement 1AP
1982-11-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →